139 related articles for article (PubMed ID: 38427576)
1. Cyclization Scaffolding for Improved Vaccine Immunogen Stability: Application to Tau Protein in Alzheimer's Disease.
Hsueh SCC; Nijland M; Aina A; Plotkin SS
J Chem Inf Model; 2024 Mar; 64(6):2035-2044. PubMed ID: 38427576
[TBL] [Abstract][Full Text] [Related]
2. De Novo Design of a β-Helix Tau Protein Scaffold: An Oligomer-Selective Vaccine Immunogen Candidate for Alzheimer's Disease.
Aina A; Hsueh SCC; Gibbs E; Peng X; Cashman NR; Plotkin SS
ACS Chem Neurosci; 2023 Aug; 14(15):2603-2617. PubMed ID: 37458595
[TBL] [Abstract][Full Text] [Related]
3. Computational design and evaluation of β-sheet breaker peptides for destabilizing Alzheimer's amyloid-β
Shuaib S; Narang SS; Goyal D; Goyal B
J Cell Biochem; 2019 Oct; 120(10):17935-17950. PubMed ID: 31162715
[TBL] [Abstract][Full Text] [Related]
4. Molecular insights into the inhibition of early stages of Aβ peptide aggregation and destabilization of Alzheimer's Aβ protofibril by dipeptide D-Trp-Aib: A molecular modelling approach.
Mohammed AA; Barale SS; Kamble SA; Paymal SB; Sonawane KD
Int J Biol Macromol; 2023 Jul; 242(Pt 3):124880. PubMed ID: 37217059
[TBL] [Abstract][Full Text] [Related]
5. Optimizing Epitope Conformational Ensembles Using α-Synuclein Cyclic Peptide "Glycindel" Scaffolds: A Customized Immunogen Method for Generating Oligomer-Selective Antibodies for Parkinson's Disease.
Hsueh SCC; Aina A; Roman AY; Cashman NR; Peng X; Plotkin SS
ACS Chem Neurosci; 2022 Aug; 13(15):2261-2280. PubMed ID: 35840132
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent binding behavior of anthraquinone derivative purpurin interacting with tau-derived peptide protofibril.
Wu X; Zhu L; Wang G; Zhang Q; Qian Z
Phys Chem Chem Phys; 2023 Oct; 25(39):26787-26796. PubMed ID: 37781899
[TBL] [Abstract][Full Text] [Related]
7. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.
Coskuner-Weber O; Uversky VN
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364151
[TBL] [Abstract][Full Text] [Related]
8. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.
Nussbaum JM; Schilling S; Cynis H; Silva A; Swanson E; Wangsanut T; Tayler K; Wiltgen B; Hatami A; Rönicke R; Reymann K; Hutter-Paier B; Alexandru A; Jagla W; Graubner S; Glabe CG; Demuth HU; Bloom GS
Nature; 2012 May; 485(7400):651-5. PubMed ID: 22660329
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of protofibril elongation and association involved in Aβ42 peptide aggregation in Alzheimer's disease.
Ghosh P; Kumar A; Datta B; Rangachari V
BMC Bioinformatics; 2010 Oct; 11 Suppl 6(Suppl 6):S24. PubMed ID: 20946608
[TBL] [Abstract][Full Text] [Related]
10. Inhibitive and Destructive Mechanisms of Chronic Traumatic Encephalopathy-Related R3-R4 Tau Peptide Chains and Protofibril by Epigallocatechin Gallate: Evidence from Molecular Dynamics Simulation.
Tang J; Sun R; Wan J; Xu Z; Gong Y; Zou Y; Zhang Q
ACS Chem Neurosci; 2023 Jun; 14(11):2098-2111. PubMed ID: 37213134
[TBL] [Abstract][Full Text] [Related]
11. Insight Into Seeded Tau Fibril Growth From Molecular Dynamics Simulation of the Alzheimer's Disease Protofibril Core.
Leonard C; Phillips C; McCarty J
Front Mol Biosci; 2021; 8():624302. PubMed ID: 33816551
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Amyloid Forming Tendency of Peptide Sequences from Amyloid Beta and Tau Proteins Using Force-Field, Semi-Empirical, and Density Functional Theory Calculations.
Muvva C; Murugan NA; Subramanian V
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33806726
[TBL] [Abstract][Full Text] [Related]
13. Study on molecular mechanisms of destabilizing Aβ(1-42) protofibrils by licochalcone A and licochalcone B using molecular dynamics simulations.
Fang M; Su K; Wang X; Guan P; Hu X
J Mol Graph Model; 2023 Jul; 122():108500. PubMed ID: 37094420
[TBL] [Abstract][Full Text] [Related]
14. Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.
Nguyen PH; Ramamoorthy A; Sahoo BR; Zheng J; Faller P; Straub JE; Dominguez L; Shea JE; Dokholyan NV; De Simone A; Ma B; Nussinov R; Najafi S; Ngo ST; Loquet A; Chiricotto M; Ganguly P; McCarty J; Li MS; Hall C; Wang Y; Miller Y; Melchionna S; Habenstein B; Timr S; Chen J; Hnath B; Strodel B; Kayed R; Lesné S; Wei G; Sterpone F; Doig AJ; Derreumaux P
Chem Rev; 2021 Feb; 121(4):2545-2647. PubMed ID: 33543942
[TBL] [Abstract][Full Text] [Related]
15. Molecular insights into Aβ
Saini RK; Shuaib S; Goyal B
J Mol Recognit; 2017 Dec; 30(12):. PubMed ID: 28850770
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic insights into the mitigation of Aβ aggregation and protofibril destabilization by a D-enantiomeric decapeptide rk10.
Singh K; Kaur A; Goyal D; Goyal B
Phys Chem Chem Phys; 2022 Sep; 24(36):21975-21994. PubMed ID: 36069400
[TBL] [Abstract][Full Text] [Related]
17. Assessing the stability of Alzheimer's amyloid protofibrils using molecular dynamics.
Lemkul JA; Bevan DR
J Phys Chem B; 2010 Feb; 114(4):1652-60. PubMed ID: 20055378
[TBL] [Abstract][Full Text] [Related]
18. Crucial role of protein oligomerization in the pathogenesis of Alzheimer's and Parkinson's diseases.
Choi ML; Gandhi S
FEBS J; 2018 Oct; 285(19):3631-3644. PubMed ID: 29924502
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Pairs of Toxic and Nontoxic Misfolded Protein Oligomers Elucidates the Structural Determinants of Oligomer Toxicity in Protein Misfolding Diseases.
Limbocker R; Cremades N; Cascella R; Tessier PM; Vendruscolo M; Chiti F
Acc Chem Res; 2023 Jun; 56(12):1395-1405. PubMed ID: 37071750
[TBL] [Abstract][Full Text] [Related]
20. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
